Mimedx (MDXG) Other financing activities (2011 - 2024)
Mimedx (MDXG) reported Other financing activities of -$1000.0 for Q4 2024, down 100.17% on a YoY basis from $594000.0 in Q1 2024, and down 100.26% sequentially from $388000.0 in Q3 2024.
Mimedx (MDXG) Other financing activities (2011 - 2024) Analysis & Trends
Mimedx (MDXG) has 14 years of Other financing activities data on file, last reported at -$1000.0 in Q4 2024.
- For the quarter ending Q4 2024, Other financing activities fell 100.17% year-over-year to -$1000.0; the trailing twelve-month figure through Sep 2025 stood at -$1000.0 (down 100.05% YoY), and the FY2024 full-year result was $1.4 million, up 39.7% from the prior year.
- Other financing activities slipped to -$1000.0 in Q4 2024, from $388000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $915000.0 in Q1 2021 to a low of -$4000.0 in Q4 2021.
- A 5-year average of $269333.3 and a median of $205000.0 in 2022 frame the typical range for Other financing activities.
- Across the five-year window, Other financing activities sank 113.33% in 2021 and soared 2025.0% in 2022, its largest moves.
- Tracing MDXG's Other financing activities over 5 years: stood at $30000.0 in 2020, then slumped by 113.33% to -$4000.0 in 2021, then soared by 2025.0% to $77000.0 in 2022, then soared by 671.43% to $594000.0 in 2023, then slumped by 100.17% to -$1000.0 in 2024.
- Business Quant data shows MDXG's Other financing activities at -$1000.0 in Q4 2024, $388000.0 in Q3 2024, and $244000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Sep 30, 2024 | 388,000.00 |
| Sep 30, 2024 | 388,000.00 |
| Jun 30, 2024 | 244,000.00 |
| Jun 30, 2024 | 244,000.00 |
| Mar 31, 2024 | 766,000.00 |
| Mar 31, 2024 | 766,000.00 |
| Dec 31, 2023 | 594,000.00 |
| Dec 31, 2023 | 594,000.00 |
| Sep 30, 2023 | 386,000.00 |
| Sep 30, 2023 | 386,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Dec 31, 2022 | 77,000.00 |
| Dec 31, 2022 | 77,000.00 |
| Sep 30, 2022 | 137,000.00 |
| Sep 30, 2022 | 137,000.00 |
| Jun 30, 2022 | 271,000.00 |
| Jun 30, 2022 | 271,000.00 |